Limited understanding of the functional diversity of N-linked glycans as a major gap of prion biology

REFERENCES

• Field EJ. Transmission experiments with multiple sclerosis: an interim report. Br Med J 1966; 2:564-5; PMID:5950508; http://dx.doi.org/10.1136/bmj.2.5513.564
   PubMed Web of Science ®Google Scholar
• Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science 1982; 216:136-44; PMID:6801762; http://dx.doi.org/10.1126/science.6801762
   PubMed Web of Science ®Google Scholar
• Bolton DC, Meyer RK, Prusiner SB. Scrapie PrP 27–30 is a sialoglycoprotein. J Virol 1985; 53:596-606; PMID:3918176
   PubMed Web of Science ®Google Scholar
• Katorcha E, Makarava N, Savtchenko R, D'Azzo A, Baskakov IV. Sialylation of prion protein controls the rate of prion amplification, the cross-species barrier, the ratio of PrPSc glycoform and prion infectivity. PLOS Pathog 2014; 10:e1004366; PMID:25211026; http://dx.doi.org/10.1371/journal.ppat.1004366
   PubMed Web of Science ®Google Scholar
• Srivastava S, Katorcha E, Daus ML, Lasch P, Beekes M, Baskakov IV. Sialylation controls prion fate in vivo. J Biol Chem 2017; 292:2359-68; PMID:27998976; http://dx.doi.org/10.1074/jbc.M116.768010
   PubMed Web of Science ®Google Scholar
• Makarava N, Savtchenko R, Alexeeva I, Rohwer RG, Baskakov IV. Fast and ultrasensitive method for quantitating prion infectivity titer. Nature Commun 2012; 3:741; http://dx.doi.org/10.1038/ncomms1730
   PubMed Web of Science ®Google Scholar
• Aguzzi A, Nuvolone M, Zhu C. The immunology of prion diseases. Nat Rev Immunology 2013; 13:888-902; PMID:24189576; http://dx.doi.org/10.1038/nri3553
   PubMed Web of Science ®Google Scholar
• Mabbott NA. Prion pathogenesis and secondary lymphoid organs. Prion 2012; 6:322-33; PMID:22895090; http://dx.doi.org/10.4161/pri.20676
   PubMed Web of Science ®Google Scholar
• Makarava N, Kovacs GG, Bocharova OV, Savtchenko R, Alexeeva I, Budka H, Rohwer RG, Baskakov IV. Recombinant prion protein induces a new transmissible prion disease in wild type animals. Acta Neuropathol 2010; 119:177-87; PMID:20052481; http://dx.doi.org/10.1007/s00401-009-0633-x
   PubMed Web of Science ®Google Scholar
• Makarava N, Kovacs GG, Savtchenko R, Alexeeva I, Budka H, Rohwer RG, Baskakov IV. Stabilization of a prion strain of synthetic origin requires multiple serial passages. J Biol Chem 2012; 287:30205-14; PMID:22807452; http://dx.doi.org/10.1074/jbc.M112.392985
   PubMed Web of Science ®Google Scholar
• Katorcha E, Daus ML, Gonzalez-Montalban N, Makarava N, Lasch P, Beekes M, Baskakov IV. Reversible off and on switching of prion infectivity via removing and reinstalling prion sialylation. Sci Rep 2016; 6:33119; PMID:27609323; http://dx.doi.org/10.1038/srep33119
   PubMed Web of Science ®Google Scholar
• Baskakov IV, Katorcha E. Multifaceted role of sialylation in prion diseases. Front Neurosci 2016; 10:358; PMID:27551257; http://dx.doi.org/10.3389/fnins.2016.00358
   PubMed Web of Science ®Google Scholar
• Aminoff D, Bruegge WF, Bell WC, Sarpolis K, Williams R. Role of sialic acid in survival of erythrocytes in the circulation: interaction of neuraminidase-treated and untreated erythrocytes with spleen and liver at the cellular level. Proc Acad Natl Sci U S A 1977; 74:1521-4; http://dx.doi.org/10.1073/pnas.74.4.1521
   PubMed Web of Science ®Google Scholar
• Linnartz B, Kopatz J, Tenner AJ, Neumann H. Sialic acid on the neuronal glycocalyx prevents complement C1 binding and complement receptor-3-mediated removal by microglia. J Neurosci 2012; 32:946-52; PMID:22262892; http://dx.doi.org/10.1523/JNEUROSCI.3830-11.2012
   PubMed Web of Science ®Google Scholar
• Wang F, Wang X, Yuan CG, Ma J. Generating a prion bacterially expressed recombinant prion protein. Science 2010; 327:1132-5; PMID:20110469; http://dx.doi.org/10.1126/science.1183748
   PubMed Web of Science ®Google Scholar
• Deleault NR, Piro JR, Walsh DJ, Wang F, Ma J, Geoghegan JC, Supattapone S. Isolation of phosphatidylethanolamine as a solitary cofactor for prion formation in the absence of nucleic acids. Proc Acad Natl Sci U S A 2012; 109:8546-51; http://dx.doi.org/10.1073/pnas.1204498109
   PubMed Web of Science ®Google Scholar
• Varki A. Sialic Acids. In: Varki A, Cummings R, Esko J, Freeze H, Hart G, Marth J, eds. Essentials of Glycobiology. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1999:195-210.
   Google Scholar
• Endo T, Groth D, Prusiner SB, Kobata A. Diversity of oligosaccharide structures linked to asparagines of the scrapie prion protein. Biochemistry 1989; 28:8380-8; PMID:2574992; http://dx.doi.org/10.1021/bi00447a017
   PubMed Web of Science ®Google Scholar
• Schauer R, Srinivasan GV, Wipfer D, Kniep B, Schwartz-Albiez R. O-Acetylated Sialic Acids and Their Role in Immune Defence. In: Wu AM, ed. The Molecular Immunology of Complex Carbohydrates-3. New York, Dordrecht, Heidelberg, London: Sprinenger Science, 2011:525-48.
   Google Scholar
• Stimson E, Hope J, Chong A, Burlingame AL. Site-specific characterization of the N-linked glycans of murine prion protein by high-performance liquid chromatography/electrospray mass spectrometry and exoglycosidase digestions. Biochemistry 1999; 38:4885-95; PMID:10200178; http://dx.doi.org/10.1021/bi982330q
   PubMed Web of Science ®Google Scholar
• Rudd PM, Endo T, Colominas C, Groth D, Wheeler SF, Harvey DJ, Wormald MR, Serban H, Prusiner SB, Kobata A, et al. Glycosylation differences between the normal and pathogenic prion protein isoforms. Proc Natl Acad Sci U S A 1999; 96:13044-9; PMID:10557270; http://dx.doi.org/10.1073/pnas.96.23.13044
   PubMed Web of Science ®Google Scholar
• Katorcha E, Makarava N, Savtchenko R, Baskakov IV. Sialylation of the prion protein glycans controls prion replication rate and glycoform ratio. Sci Rep 2015; 5:16912; PMID:26576925; http://dx.doi.org/10.1038/srep16912
   PubMed Web of Science ®Google Scholar
• Baskakov IV, Breydo L. Converting the prion protein: What makes the protein infectious. Biochim Biophys Acta (Molecular Basis of Disease) 2007; 1772:692-703; http://dx.doi.org/10.1016/j.bbadis.2006.07.007
   PubMed Web of Science ®Google Scholar
• Rabinovich GA, Croci DO. Regulatori Circuits Mediated by Lectin-Glycan Interaction in Autoimmunity and Cancer. Immunity 2012; 36:322-35; PMID:22444630; http://dx.doi.org/10.1016/j.immuni.2012.03.004
   PubMed Web of Science ®Google Scholar
• Linnartz B, Bodea L-G, Neumann H. Microglia carbohydrate-binding receptors for neural repair cell tissue repair. Cell Tissue Res 2012; 349:215-27.
   PubMed Web of Science ®Google Scholar
• Katorcha E, Klimova N, Makarava N, Savtchenko R, Pan X, Annunziata I, Takahashi K, Miyagi T, Pshezhetsky AV, d'Azzo A, et al. Knocking out of cellular neuraminidases Neu1, Neu3 or Neu4 does not affect sialylation status of the prion protein. PLoS One 2015; 10:e0143218; PMID:26569607; http://dx.doi.org/10.1371/journal.pone.0143218
   PubMedGoogle Scholar
• Srivastava S, Makarava N, Katorcha E, Savtchenko R, Brossmer R, Baskakov IV. Post-conversion sialylation of prions in lymphoid tissues. Proc Acad Natl Sci U S A 2015; 112:E6654-62; http://dx.doi.org/10.1073/pnas.1517993112
   PubMed Web of Science ®Google Scholar
• Kleene R, Schachner M. Glycans and neural cell interactions. Nat Rev Neurosci 2004; 5:195-208; PMID:14976519; http://dx.doi.org/10.1038/nrn1349
   PubMed Web of Science ®Google Scholar